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We report the selection and characterization of influenza A/NWS-G70c and B/HK/8/73 (HG) viruses which are resistant
to the potent influenza neuraminidase inhibitor, 4-guanidino-Neu5Ac2en. Viruses were selected which replicated in MDCK
cells in the presence of 20 mg/ml inhibitor. The neuraminidase of resistant viruses was 200-fold more resistant to 4-
guanidino-Neu5Ac2en than was the neuraminidase of the parent viruses. Although amounts of neuraminidase protein
were similar in resistant and parent viruses, the enzyme activity of the resistant neuraminidase heads was reduced by
95% for the substrates used. Relative to parent viruses, the resistant viruses replicated to equal or greater titers in
tissue culture and in embryonated chicken eggs. Sequence analysis revealed a single nucleotide mutation in the neuramini-
dase gene of each virus resulting in the change of the conserved Glu 119 (which lies in a pocket beneath the active site
of the enzyme) to Gly thus eliminating an electrostatic interaction with the C-4 guanidinium moiety of the inhibitor.
Mutations (Asn r Ser) at amino acids 145 and 150 were also found in the hemagglutinin gene of the B/HK/8/73 (HG)
virus resistant to 4-guanidino-Neu5Ac2en. No changes were found in the hemagglutinin gene of the resistant A/NWS-
G70c virus. q 1995 Academic Press, Inc.
Influenza viruses encode two envelope glycoproteins, electrostatic interaction with the conserved glutamic
neuraminidase (NA) and hemagglutinin (HA), for which acids at amino acid positions 119 and 227 (6, 9).
high resolution crystal structures are available (1, 2). HA Here, the selection of influenza A and B viruses for
mediates attachment of the virus to the host cell and resistance to 4-GuDANA is reported. 4-Guanidino-2-
fusion with the endosomal membrane. NA (EC 3.2.1.18; deoxy-2,3-didehydro-D-N-acetylneuraminic acid (4-Gu-
sialidase, neuraminidase, acylneuraminylhydrolase) cat- DANA) was synthesized according to published proce-
alyzes the removal of terminal sialic acid residues from dures with modifications (10, 11). The reassortant influ-
viral and cellular glycoconjugates and facilitates the re- enza viruses A/NWS/33HA-A/Tern/Australia/G70c/75NA ,
lease of virus from the infected cell. referred to as A/NWS-G70c (12), and the high-titer grow-
The catalytic sites of the neuraminidases from all influ- ing influenza B/HK/8/73 (HG), which has the HA of B/
enza A and B viruses so far examined are structurally Hong Kong/8/73 and the NA of B/Lee/40 (13), were grown
very similar (3, 4) and several amino acids which line the in Madin-Darby canine kidney (MDCK) cells in step-wise
active site of the enzyme and participate directly in the increases of 4-GuDANA up to a concentration of 20 mg/
binding and catalysis of the substrate are invariant (re- ml and plaque purified three times in 5 to 10 mg/ml of
viewed in 5). This suggests that an active-site inhibitor inhibitor. The 4-GuDANA resistant (4-GuDANAr) viruses,
effective against one strain should, in principle, be effec- unlike parent viruses, were able to replicate and induce
tive against all strains of influenza A and B viruses. A cytopathic effects in MDCK cells in the presence of 5
structure-based approach to the design of influenza neur- mg/ml 4-GuDANA (Fig. 1). In additional studies, using
aminidase inhibitors led to the discovery that the sialic a standard plaque assay (14) performed in triplicate to
acid analog, 4-guanidino-Neu5Ac2en (4-GuDANA), is a estimate 50% inhibitory end-points (15), the concentration
potent inhibitor of the enzyme as well as influenza virus of 4-GuDANA required to reduce the number of plaques
replication (6 – 8). This inhibitor binds in the catalytic site by 50% was 0.2 mg/ml for A/NWS-G70c, 4.6 mg/ml for 4-
of influenza virus NA and it has been shown that the GuDANAr A/NWS-G70c, 0.07 mg/ml for B/HK/8/73 (HG),
C-4 guanidinium moiety of the inhibitor forms a strong and 6.0 mg/ml for 4-GuDANAr B/HK/8/73 (HG).
The activity of virion associated or purified neuramini-
dases from parent or 4-GuDANAr influenza A and B vi-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (317) 276-1743. ruses was assayed using either fetuin (16) or 2*-(4-meth-
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FIG. 2. Inhibition of virion-associated NA by 4-GuDANA. Using fetuin
as the substrate (16), NA activity associated with A/NWS-G70c (j), 4-
GuDANAr A/NWS-G70c (h), B/HK/8/73 (HG) (l), or 4-GuDANAr B/HK/
8/73 (HG) (s) virions was assayed in the absence or presence of
increasing concentrations of 4-GuDANA. The concentration of 4-Gu-
DANA required to inhibit neuraminidase activity by 50% (15) was 0.05
mg/ml for A/NWS-G70c, 15.5 mg/ml for 4-GuDANAr A/NWS-G70c, 0.10
mg/ml for B/HK/8/73 (HG), and 20 mg/ml for 4-GuDANAr B/HK/8/73
(HG). Similar results were obtained using NA heads purified from resis-
tant and parent viruses (data not shown).
ylumbelliferyl)-a-D-N-acetylneuraminic acid (MUN) (17)
as the substrate. The NA activity associated with 4-Gu-
DANAr virions, as determined using fetuin as the sub-
strate, was 200-fold more resistant to inhibition by
4-GuDANA than was enzyme activity associated with
parent viruses (Fig. 2). The NA activity of 4-GuDANAr
influenza A and B viruses was also resistant to 2-deoxy-
2,3-dehydro-N-acetylneuraminic acid (DANA; data not
shown).
NA heads were prepared by protease digestion of vi-
rus particles obtained from infected 11-day-old em-
bryonated chicken eggs and purified by sucrose gradient
centrifugation as previously described (12, 18). When
normalized for protein content, purified NA heads from
4-GuDANAr influenza A or B viruses displayed much less
NA activity for both fetuin and MUN substrates when
compared to NA heads from parent viruses (Table 1). The
decrease in enzyme activity was not due to a decrease in
the NA protein content of the resistant viruses since the
without 5 mg/ml of 4-GuDANA at 377. After 72 hr, phase-contrast photo-
micrographs (400X) of the cell monolayers were taken. (A) mock in-
fected. (B) A/NWS-G70c infected and untreated. (C) A/NWS-G70c
treated with 4-GuDANA. (D) 4-GuDANAr A/NWS-G70c infected and un-
treated. (E) 4-GuDANAr A/NWS-G70c infected and treated with 4-Gu-
FIG. 1. Effect of 4-GuDANA on the replication of parent and 4-GuDA- DANA. (F) B/HK/8/73 (HG) infected and untreated. (G) B/HK/8/73 (HG)
NAr influenza A and B viruses. MDCK cells were infected with the infected and treated with 4-GuDANA. (H) 4-GuDANAr B/HK/8/73 (HG)
parent viruses, A/NWS-G70c or B/HK/8/73 (HG) or the 4-GuDANAr vi- infected and untreated. (I) 4-GuDANAr B/HK/8/73 (HG) infected and
ruses derived from these and incubated in growth medium with or treated with 4-GuDANA.
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TABLE 1 and B/HK/8/73 (HG) viruses were determined using syn-
thetic oligonucleotide primers according to standard pro-Relative Activities of NA Purified from Parent and
cedures (21, 22). The NA gene of the 4-GuDANAr A/NWS-4-GuDANAr Influenza A and B Viruses
G70c (N9) virus was found to have a single mutation
Virusa MUNb Fetuin leading to the amino acid substitution, Glu r Gly at posi-
tion 119 (N2 numbering). Similarly, the NA gene of the
A/NWS-G70c 100%c 100%
4-GuDANAr B/HK/8/73 (HG) also had a single mutation4-GuDANAr A/NWS-G70c 4.9% 5.0%
leading to the amino acid substitution Glu r Gly at posi-B/HK/8/73 (HG) 100% NDd
4-GuDANAr B/HK/8/73 (HG) 0.6% ND tion 119. This glutamic acid lies in a pocket beneath
the active site of the enzyme (2, 6, 9) and is absolutely
a Virus was obtained from the allantoic fluid of 11-day embryonated conserved among all known influenza virus neuramini-
chickens eggs and purified by adsorption to and elution from chicken
dases (Fig. 4). Our data provide genetic evidence in sup-red blood cells followed by sucrose gradient centrifugation as pre-
port of recent structural findings which show a strongviously described (18). NA heads were obtained by protease digestion
of purified virus particles (12). electrostatic interaction between the carboxylate of Glu
b Fetuin and the fluorogenic subtrate, 2*-(4-methylumbelliferyl)-a-D- 119 and the C-4 guanidinium group of 4-GuDANA (6, 9).
N-acetylneuraminic acid (MUN), were purchased from Sigma Chemical The replacement of Glu 119 with Gly in viruses which
Co. (St. Louis, MO). The activity of purified neuraminidases from parent
are resistant to 4-GuDANA underscores the importanceand 4-GuDANAr influenza A and B viruses was assayed using either
of this interaction as the basis for the inhibitory activityfetuin (16) or MUN (17 ) as the substrate and was normalized to neur-
aminidase protein content. of this sialic acid analog.
c The level of NA activity for each of the parent A and B influenza There were no differences between the HA gene of
virus enzymes was set to 100% and the level of enzymatic activity of the parent A/NWS-G70c virus and that of the 4-GuDANAr
the 4-GuDANAr neuraminidases is relative to that of the respective
mutant. In contrast, two mutations were observed in theparent enzyme. Similar results were obtained using virions as the
HA gene from 4-GuDANAr B/Hong Kong/8/73 (HG); onesource of NA (data not shown).
d Not determined. at nucleotide position 489 and the other at nucleotide
position 504, both resulting in a codon change of AAC
r AGC yielding changes of Asn r Ser at amino acids
145 and 150. This suggests that, at least for this type Byield of purified NA from resistant and parent viruses
was similar (data not shown). Although the 4-GuDANAr virus, alterations in the HA, in response to the selective
pressure of 4-GuDANA, may play a role in the resistanceviruses were found to have markedly lower levels of NA
activity than did parent viruses, the resistant viruses repli- to this inhibitor. Since Asn 145 is part of a Asn-X-Ser/
cated to high titers in embryonated eggs (data not
shown). In MDCK cells, 4-GuDANAr influenza A and B
viruses were not impaired for multicycle replication. The
resistant A/NWS-G70c virus replicated to peak titers
which were equivalent to those of the parent virus, al-
though this virus displayed delayed kinetics reaching a
maximum titer 12 hr later than did the parent virus (Fig.
3). The resistant B/HK/8/73 (HG) virus displayed normal
replication kinetics and grew to higher titers than did the
parent virus (Fig. 3). The results here indicate that the
greatly reduced levels of NA activity associated with 4-
GuDANAr viruses are sufficient to permit multiple cycles
of replication in tissue culture and in ovo. Along these
lines, an A/WSN/33 virus containing an altered NA dis-
played only approximately 10% of the wild-type NA activ-
ity yet was still capable of multiple rounds of replication
in MDCK cells (19). However, the complete lack of NA
results in the aggregation of virus particles at the infected
cell surface and the inability to undergo multicycle repli-
cation (20). FIG. 3. Replication of parent and 4-GuDANAr influenza A and B vi-
ruses in MDCK cells. MDCK cells were infected with A/NWS-G70c (j),Influenza A and B viruses were obtained from 11-day-
4-GuDANAr A/NWS-G70c (h), B/HK/8/73 (HG) (m), or 4-GuDANAr B/old embryonated chicken eggs and purified on sucrose
HK/8/73 (HG) (n) at a multiplicity of 0.001 and the infected cells weregradients, as was done for the preparation of NA heads,
incubated in medium without 4-GuDANA. At the indicated times post-
and were used as the source of viral RNA for sequence infection, cell culture fluid was harvested and the virus titer was deter-
analysis. The complete nucleotide sequences of NA and mined in MDCK cells using a standard plaque assay in the absence
of 4-GuDANA (14).HA genes from parent and from 4-GuDANAr A/NWS-G70c
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FIG. 4. Alignment of the amino acid sequences of different influenza virus neuraminidases in the region surrounding Glu 119 (N2 numbering).
Conserved amino acids are indicated by upper case letters. The conserved Glu which is changed to Gly in the 4-GuDANAr mutants is shown in
bold type and boxed. Active site amino acids which directly contact sialic acid are shaded. Second shell amino acids are shown in bold type.
Sequence comparison of the NA genes from parent A/NWS-G70c and B/HK/8/73 (HG) and the 4-GuDANAr viruses revealed a single substitution
at nucleotide position 377 (A virus) or 403 (B virus) resulting in a codon change of GAA r GGA yielding a change at amino acid position 120 (N9
numbering) or 117 (B/Lee/40 numbering) of Glu r Gly.
Thr consensus sequence for N-linked glycosylation, the to collect X-ray diffraction data from these crystals. The
mutant B/Lee/40 NA has so far produced only very smallchange of this amino acid to Ser would eliminate this
glycosylation site. Because of the change from Asn r irregular crystals, not suitable for analysis by x-ray dif-
fraction, in contrast to the parent B/Lee/40 enzyme whichSer at amino acid 150, Asn 148 becomes a potential site
for the attachment of a glycosyl group. If this is indeed formed crystals of high quality. These results suggest
that the sequence change of Glu 119 r Gly affects notthe case, the new location of the carbohydrate moiety
(at Asn 148) in the HA of 4-GuDANAr B/HK/8/73 (HG) only the enzyme activity of the NA but also the surface
properties of the enzyme. The exact structural changesvirus could conceivably affect the availability and/or the
affinity of this envelope glycoprotein for its sialic acid involved will not be fully appreciated until X-ray diffraction
quality crystals of the mutant enzymes can be grown.receptor. Alternatively, alterations in the glycosylation
pattern of HA might affect the cleavability of HA by host The clinical relevance of the work reported here re-
mains to be determined and two issues need to be ad-cell protease(s), a step which is essential for entry of
influenza virus into the host cell (23). Because of the role dressed: (1) It would be of great interest to determine
whether influenza viruses which are resistant to 4-Gu-of NA in the cleavage of HA by cellular protease(s) (19,
24), the alteration in HA of the 4-GuDANAr virus might DANA display altered pathogenicity and virulence in an
animal model of infection. (2) Although influenza A andbe a compensatory response to the greatly reduced NA
levels associated with this virus. The HA genes from B viruses resistant to 4-GuDANA were isolated readily
in tissue culture, the experiments described here do notother strains of influenza A and B viruses selected for
resistance to 4-GuDANA will have to be sequenced in provide an estimate of the frequency at which the drug-
resistant mutants can be isolated in a population of vi-order to determine the general relevance of these results.
The determination of whether the Glu r Gly change ruses. In preliminary experiments in animals treated with
this inhibitor, the appearance of influenza virus resistantfound in the NA of 4-GuDANAr influenza viruses is suffi-
cient to confer resistance to this inhibitor will require the to 4-GuDANA could not be demonstrated (6). In a clinical
study of experimental influenza virus infection, 4-Gu-introduction of the necessary mutation into the NA gene
of influenza viruses using the technique of reverse genet- DANA demonstrated therapeutic efficacy against influ-
enza A/Texas/91 (H1N1) infection but the emergence ofics (25). Furthermore, the introduction of the HA muta-
resistant virus was not reported (27).tions reported here into HA gene of influenza B virus, in
the absence of any changes in the NA gene, would eluci-
date the contribution, if any, of these changes to the 4- ACKNOWLEDGMENTS
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